Filing excerpt
Dectomax®-CA1 Injectable, the first parasite control product for the prevention and treatment of New World screwworm myiasis in cattle, received conditional approval in the U.S. from the FDA in 2025;
Source: Autobound Signal API · 77 signals tracked for Zoetis · updated
Get Zoetis' live signals in Claude or ChatGPT, or by API
What changed at Zoetis this week? Use Autobound signals for zoetis.com.The company received approvals for several key products in 2025, such as Lenivia and Portela for OA pain and a new label for Simparica Trio.
Filing excerpt
Dectomax®-CA1 Injectable, the first parasite control product for the prevention and treatment of New World screwworm myiasis in cattle, received conditional approval in the U.S. from the FDA in 2025;
What this signalsFilings often name leadership changes, deals and spending plans.
Technologies
Regions named
sec-10kproductLaunchGet every 10-K signal for Zoetis and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Zoetis this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/7df7bed0-5cd3-415d-9347-63ee80add717 returns this record as JSON. POST /v1/companies/enrich returns every signal for zoetis.com.
{
"signal_id": "7df7bed0-5cd3-415d-9347-63ee80add717",
"signal_type": "sec-10k",
"signal_subtype": "productLaunch",
"detected_at": "2026-02-17T06:31:12.916+00:00",
"company": {
"name": "Zoetis",
"domain": "zoetis.com"
},
"data": {
"detail": "The company received approvals for several key products in 2025, such as Lenivia and Portela for OA pain and a new label for Simparica Trio. This wave of commercialization requires significant budget for marketing, sales force training, supply chain logistics, and pharmacovigilance systems.",
"metrics": {
"timeframe": "current_year"
},
"summary": "Zoetis launched multiple new products and indications in 2025, including Lenivia, Portela, and Dectomax-CA1.",
"excerpts": "Dectomax®-CA1 Injectable, the first parasite control product for the prevention and treatment of New World screwworm myiasis in cattle, received conditional approval in the U.S. from the FDA in 2025;",
"relevance": 0.8,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1555280/000155528026000011/zts-20251231.htm",
"filing_date": "2026-02-12",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "Go-to-market support",
"signal_category": "strategic",
"regions_mentioned": [
"U.S.",
"EU",
"Canada"
],
"technologies_mentioned": [
"monoclonal antibody (mAb)"
]
}
}
curl https://signals.autobound.ai/v1/signals/7df7bed0-5cd3-415d-9347-63ee80add717 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"zoetis.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.